share_log

EF Hutton Maintains Buy on ISpecimen, Lowers Price Target to $4.25

EF Hutton Maintains Buy on ISpecimen, Lowers Price Target to $4.25

EF Hutton 维持对iSpecimen的买入,将目标股价下调至4.25美元
Benzinga Real-time News ·  2022/09/23 10:52

EF Hutton analyst Constantine Davides maintains iSpecimen (NASDAQ:ISPC) with a Buy and lowers the price target from $5.5 to $4.25.

EF Hutton分析师康斯坦丁·戴维斯维持iSpecimen(纳斯达克股票代码:ISPC)的买入,并将目标股价从5.5美元下调至4.25美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发